Scienceonline - Last News

Covid-19 vaccination: thrombosis can be prevented by prompt treatment

Covid-19 vaccination: thrombosis can be prevented by prompt treatment

17 Maggio 2021

A rare syndrome has been observed in people following vaccination...

Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice

Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice

29 Aprile 2021

AbstractNeutralizing antibodies that target the receptor-binding domain (RBD) of the...

The mystery of a Picasso unveiled by scientists

The mystery of a Picasso unveiled by scientists

21 Aprile 2021

Pablo PicassoSeated ManBarcelona, June-November 1917Oil on canvas104 x 54 cmMuseu...

Water purification system engineered from wood, with help from a microwave oven

Water purification system engineered from wood, with help from a microwave oven

16 Aprile 2021

Before and after. On the left is an aqueous solution...

The Indonesian Lusi eruption – a significant source of greenhouse gases

The Indonesian Lusi eruption – a significant source of greenhouse gases

12 Aprile 2021

The main Lusi vent and its plume during regular geysering...

Exercise promotes healthy living and a healthy liver

Exercise promotes healthy living and a healthy liver

12 Aprile 2021

Researchers at the University of Tsukuba show that in non-alcoholic...

Aluminum Is Intricately Associated with the Neuropathology of Familial Alzheimer’s Disease

Aluminum Is Intricately Associated with the Neuropathology of Familial Alzheimer’s Disease

12 Aprile 2021

The image shows aluminum (orange) in a neuron in a...

Bacteria help plants grow better

Bacteria help plants grow better

09 Aprile 2021

Study by the University of Bonn may in the long...

Sabato, 04 Marzo 2017

Rheumatoid arthritis: New treatment option for difficult-to-treat patients

 

Between 3 and 5% of the population suffer from a form of inflammatory rheumatism. It affects approximately 250,000 – 400,000 people in Austria. Rheumatoid arthritis is one of the commonest and also the most dangerous forms of this inflammatory rheumatic disease. Around 30% of patients achieve remission, that is to say successful control of symptoms, after just one or two years. However, despite frequent changes in treatment, many other patients have to endure the active form of the disease on an ongoing basis. A multicentre, multinational study headed up by rheumatologist Daniel Aletaha of MedUni Vienna as principal investigator has now shown that a new drug (sirukumab) is a very promising treatment option for these "refractory" patients. The study has now been published in the world-leading journal "The Lancet".

Pubblicato in Scienceonline

 

Scienzaonline con sottotitolo Sciencenew  - Periodico
Autorizzazioni del Tribunale di Roma – diffusioni:
telematica quotidiana 229/2006 del 08/06/2006
mensile per mezzo stampa 293/2003 del 07/07/2003
Scienceonline, Autorizzazione del Tribunale di Roma 228/2006 del 29/05/06
Pubblicato a Roma – Via A. De Viti de Marco, 50 – Direttore Responsabile Guido Donati

Photo Gallery